AG
Asthika Goonewardene Truist Securities Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Revolution Medicines
RVMD
$7.57B
| $40.50 | $99 |
144%
upside
| Buy | yesterday |
|
2
Gilead Sciences
GILD
$143B
| $115.05 | $127 |
10%
upside
| Buy | 29 days ago |
|
3
Exelixis
EXEL
$10.2B
| $37.88 | $49 |
29%
upside
| Buy | 1 month ago |
|
4
Genmab
GMAB
$16.9B
| $27.54 | $46 |
67%
upside
| Buy | 2 months ago |
|
5
BioNTech
BNTX
$27B
| $112.46 | $155 |
38%
upside
| Buy | 3 months ago |
|
6
Legend Biotech
LEGN
$6.66B
| $36.08 | $71 |
97%
upside
| Buy | 3 months ago |
|
7
Allogene Therapeutics
ALLO
$255M
| $1.15 | $10 |
770%
upside
| Buy | 3 months ago |
|
|
AUTL
8
Autolus Therapeutics
AUTL
$389M
| $1.46 | $10 |
585%
upside
| Buy | 5 months ago |
|
9
Iovance Biotherapeutics
IOVA
$901M
| $2.49 | $15 |
502%
upside
| Buy | 6 months ago |
|
10
Summit Therapeutics
SMMT
$19.3B
| $25.98 | $35 |
35%
upside
| Buy | 8 months ago |
|
11
Arcellx
ACLX
$4.03B
| $72.62 | $136 |
87%
upside
| Buy | 9 months ago |
|
12
Arcus Biosciences
RCUS
$1.3B
| $12.19 | $44 |
261%
upside
| Buy | 1 year ago |
|
13
Merus
MRUS
$5.1B
| $67.47 | $88 |
30%
upside
| Buy | 1 year ago |
|
|
AUTL
14
Autolus Therapeutics
AUTL
$389M
| $1.46 | $38 |
2,503%
upside
| Buy | 5 years ago |
|
|
15
Genmab
GMAB
$16.9B
| $27.54 | $39 |
42%
upside
| Buy | 5 years ago |
|
|
16
Exelixis
EXEL
$10.2B
| $37.88 | $40 |
6%
upside
| Buy | 5 years ago |
|
|
17
Allogene Therapeutics
ALLO
$255M
| $1.15 | $32 |
2,683%
upside
| Hold | 5 years ago |
|